HK Stock MarketDetailed Quotes
02496 YZYBIO-B
- 7.480
- 0.0000.00%
Not Open Jul 16 16:08 CST
1.45BMarket Cap-6856P/E (TTM)
0.000High0.000Low0Volume7.480Open7.480Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)193.85MShares19.80052wk High10.29P/B833.79MFloat Cap7.44052wk Low--Dividend TTM111.47MShs Float19.800Historical High--Dividend LFY0.00%Amplitude7.440Historical Low--Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
YZYBIO-B Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||
| Earning before tax | -1.50%-191.7M | ---- | -27.17%-188.87M | ---- | -37.71%-148.52M | ---56.59M | ---107.85M |
| Profit adjustment | |||||||
| Interest (income) - adjustment | -269.96%-1.05M | ---- | -74.69%-283K | ---- | -390.91%-162K | ---54K | ---33K |
| Impairment and provisions: | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Revaluation surplus: | -139.64%-1.61M | --0 | 46.79%-671K | --0 | -3,967.74%-1.26M | ---416K | ---31K |
| -Other fair value changes | -139.64%-1.61M | ---- | 46.79%-671K | ---- | -3,967.74%-1.26M | ---416K | ---31K |
| Asset sale loss (gain): | 666.67%23K | --0 | -99.45%3K | --0 | 1,090.91%545K | ---33K | ---55K |
| -Loss (gain) on sale of property, machinery and equipment | 666.67%23K | ---- | -99.45%3K | ---- | 1,090.91%545K | ---33K | ---55K |
| Depreciation and amortization: | 5.36%7.32M | --0 | -8.84%6.94M | --0 | -2.27%7.62M | --3.99M | --7.79M |
| -Depreciation | 5.36%7.32M | ---- | -8.84%6.94M | ---- | -2.27%7.62M | --3.99M | --7.79M |
| Financial expense | -3.24%2.39M | ---- | -83.52%2.47M | ---- | 274.67%14.97M | --10.44M | --4M |
| Exchange Loss (gain) | --1.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items | ---- | ---- | -96.00%1.58M | ---- | 100.28%39.65M | --1.83M | --19.8M |
| Operating profit before the change of operating capital | -2.18%-182.71M | --0 | -105.16%-178.82M | --0 | -14.12%-87.16M | ---40.83M | ---76.38M |
| Change of operating capital | |||||||
| Inventory (increase) decrease | 383.97%4.85M | ---- | -231.84%-1.71M | ---- | 76.60%-515K | --2.24M | ---2.2M |
| Accounts payable increase (decrease) | 160.49%12.52M | ---- | 33.24%4.81M | ---- | 284.41%3.61M | ---2.37M | ---1.96M |
| prepayments (increase)decrease | -32.02%-10.47M | ---- | 10.06%-7.93M | ---- | -799.21%-8.82M | ---5.1M | --1.26M |
| Cash from business operations | -5.27%-186.02M | --0 | -79.01%-176.7M | --0 | -20.55%-98.71M | ---48.07M | ---81.89M |
| Other taxs | -252.84%-7.87M | ---- | 184.79%5.15M | ---- | -638.15%-6.08M | ---1.47M | ---823K |
| Special items of business | -229.72%-2.34M | ---- | 617.13%1.8M | ---- | 114.04%251K | ---536K | ---1.79M |
| Net cash from operations | -5.27%-186.02M | 6.47%-72.32M | -79.01%-176.7M | -60.86%-77.32M | -20.55%-98.71M | ---48.07M | ---81.89M |
| Cash flow from investment activities | |||||||
| Interest received - investment | 269.96%1.05M | 333.33%182K | 74.69%283K | -22.22%42K | 390.91%162K | --54K | --33K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | -37.33%47K | --47K | --75K |
| Purchase of fixed assets | -36.78%-1.93M | -179.25%-1.41M | 25.85%-1.41M | 31.62%-506K | -215.07%-1.9M | ---740K | ---604K |
| Recovery of cash from investments | 40.08%492.61M | 477.10%477.34M | -24.10%351.67M | -31.20%82.71M | 12,319.22%463.36M | --120.23M | --3.73M |
| Cash on investment | -17.31%-444M | -555.22%-439M | 21.41%-378.5M | 44.40%-67M | ---481.6M | ---120.5M | ---- |
| Other items in the investment business | -79.02%7.08M | --7.11M | --33.76M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 844.30%54.81M | 190.00%44.23M | 129.12%5.8M | 1,770.32%15.25M | -716.17%-19.93M | ---913K | --3.24M |
| Net cash before financing | 23.22%-131.21M | 54.74%-28.09M | -44.04%-170.9M | -26.73%-62.07M | -50.85%-118.64M | ---48.98M | ---78.65M |
| Cash flow from financing activities | |||||||
| New borrowing | 16.99%89.5M | -68.00%20M | 173.21%76.5M | 123.21%62.5M | -69.95%28M | --28M | --93.17M |
| Refund | -173.21%-76.5M | -137.50%-66.5M | 69.59%-28M | 69.59%-28M | -820.70%-92.07M | ---92.07M | ---10M |
| Issuing shares | -13.02%173.96M | ---- | 37.73%200M | ---- | 24.12%145.21M | --40M | --116.99M |
| Interest paid - financing | 3.24%-2.39M | -87.34%-1.44M | 38.27%-2.47M | 79.43%-766K | -220.35%-4M | ---3.72M | ---1.25M |
| Absorb investment income | ---- | ---- | ---- | ---- | --4.7M | --4.7M | ---- |
| Issuance expenses and redemption of securities expenses | -75.86%-7.5M | 28.61%-534K | -973.55%-4.26M | ---748K | ---397K | ---- | ---- |
| Other items of the financing business | -79.13%-781K | -141.98%-513K | -6.08%-436K | -6.00%-212K | -29.65%-411K | ---200K | ---317K |
| Net cash from financing operations | -26.95%176.29M | -249.45%-48.98M | 197.82%241.33M | 240.70%32.77M | -59.20%81.03M | ---23.29M | --198.6M |
| Effect of rate | ---1.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -38.72%43.16M | -163.09%-77.08M | 287.28%70.44M | 59.46%-29.3M | -131.36%-37.61M | ---72.27M | --119.94M |
| Begining period cash | 84.77%153.52M | 84.77%153.52M | -31.16%83.09M | -31.16%83.09M | 15,992.53%120.69M | --120.69M | --750K |
| Cash at the end | 28.12%196.68M | 42.12%76.45M | 84.77%153.52M | 11.08%53.79M | -31.16%83.09M | --48.42M | --120.69M |
| Cash balance analysis | |||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg